Cleopatra Hospitals Group results, Q3 2023
Net profit, assets, equity and cash flow for Q3 2023, against the same period a year earlier, from the published financial statements.
Net profit120 millionEGP · +45.1% vs the same period a year earlier
Total assets3.99 billionEGP · +26.4% vs the same period a year earlier
Shareholders' equity2.32 billionEGP · +18.9% vs the same period a year earlier
Operating cash flow238 millionEGP · +161.0% vs the same period a year earlier
In short
- Cleopatra Hospitals Group's net profit for Q3 2023 was about 120 million EGP, up +45.1% from 82.51 million EGP in Q3 2022.
- Total assets at the end of Q3 2023 were about 3.99 billion EGP, and shareholders' equity about 2.32 billion EGP.
- Operating cash flow for Q3 2023 was positive at 238 million EGP.
Key lines against the same period a year earlier
This periodQ3 2022Change
Net profit120 million82.51 million+45.1%
Gross profit358 million256 million+40.2%
Total assets3.99 billion3.16 billion+26.4%
Total liabilities1.68 billion1.21 billion+38.6%
Shareholders' equity2.32 billion1.95 billion+18.9%
Total liabilities and equity3.99 billion3.16 billion+26.4%
Operating cash flow238 million91.36 million+161.0%
Investing cash flow-197 million-110 million−79.6%
Financing cash flow-10.24 million53.92 million−119.0%
Net change in cash30.83 million35.36 million−12.8%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Cleopatra Hospitals Group's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy